CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
This study is trying to identify the right dose of a long-acting medicine called WIN378 for people with moderate or severe asthma. WIN378 bl...
Phase 2
Berlin, Loire-Atlantique, Germany and 72 other locations
The primary purpose of this study is to evaluate the long-term safety and efficacy of verekitug (UPB-101) in participants who complete the VALIANT st...
Phase 2
Berlin, Germany, Germany and 101 other locations
This study is trying to find the right dose of a long-lasting medicine called GSK5784283 for people with asthma that remains uncontrolled ev...
Phase 2
Berlin, Germany and 133 other locations
This study evaluates the efficacy and safety of benralizumab as an add-on therapy in uncontrolled eosinophilic asthma participants treated w...
Phase 3
Berlin, Germany and 166 other locations
This study is researching a drug called dupilumab. The study is focused on patients who have uncontrolled asthma. Asthma is a condi...
Phase 4
Berlin, Germany and 77 other locations
This study will compare an asthma inhaler that uses a new climate friendly alternative propellant to an asthma inhaler with an exis....
Phase 2
Berlin, Germany and 166 other locations
This Phase 2b study is designed to evaluate the safety and efficacy of KT-621 in participants with uncontrolled moderate to severe eosinophilic asthma...
Phase 2
Berlin, Germany and 57 other locations
This study is testing the safety, tolerability, pharmacokinetics and pharmacodynamics of GB-0895.
Phase 1
Berlin, Germany and 13 other locations
levels compared with placebo in participants with moderate-to-severe asthma.Study participation will last approximately 65 weeks, including ...
Phase 2
Berlin, Germany and 120 other locations
This is a parallel-group, Phase 2, randomized, double-blind, placebo-controlled, 2-arm study for the treatment of asthma.The purpose of this...
Phase 2
Berlin, Germany and 238 other locations
Clinical trials
Research sites
Resources
Legal